-
European, Mideast foreign ministers push peace and diplomacy at Istanbul talks
-
Bayern Munich coach Kompany in hospital after collapsing: club
-
Ex-All Black centre Williams undergoes 'miracle' heart surgery
-
Alonso sees Courtois similarities in Chelsea's Penders
-
Netanyahu launches major West Bank operation after Israeli soldiers killed
-
Melania Trump announces truce in Ukrainian city 'on brink of disaster'
-
AFP photographer captures striking images from West Bank attack
-
Saka to be carefully managed after latest injury setback, says Arteta
-
Oil hits $116 with stocks mixed on earnings, AI
-
Goodell says NFL's France debut 'just the beginning'
-
De Zerbi says Tottenham's dire record at Chelsea 'more motivation'
-
Singapore widens haze probe to local firms linked to Indonesian fires
-
Lula, Bolsonaro in final debate showdown before Brazil vote
-
Hundreds of Syrians protest repeated Israeli incursions
-
Poulter latest golfer to leave LIV
-
El Salvador sends troops to Haiti to find 4 missing soldiers
-
Gunman kills one, wounds five in town outside Paris
-
Liverpool must go 'full gas' despite injury issues, says Iraola
-
Melania Trump says secured ceasefire in Ukrainian city of Oleshky
-
Oil hits $115 with stocks mixed on earnings, AI
-
Carrick 'confident' he can turn around Man Utd slump
-
Casualties feared as multi-storey building collapses in Nairobi
-
PSG v Lyon French Ligue 1 game postponed due to Paris protests
-
Man Utd defeat to Como 'unacceptable', says Carrick
-
Meghan Markle 'distressed' over claims father had child abuse images
-
Hurzeler 'focused' on Brighton job despite Man Utd links
-
Gunman kills one, wounds four in town outside Paris
-
Hammer blow for Kenya as world marathon champ Jepchirchir suspended for doping
-
France to deploy 70,000 police ahead of new protests
-
Latin America's right-wing swing looms large over nature summit
-
Mekies hails Verstappen as Red Bull's driving force amid revival
-
European, Mideast foreign ministers hold talks in Istanbul
-
Tanker with Russian diesel heads to New York under Trump deal
-
World marathon champion Peres Jepchirchir suspended for doping: AIU
-
New centre puts focus on Portuguese dictator Salazar's legacy
-
Romania blames Russia for new deadly attack on ship
-
Oil nears $115 with stocks mixed on earnings, AI
-
Waze rejects Malaysia's data security claims after civil servant ban
-
Asian football endorses Infantino re-election in apparent U-turn
-
'Call of Duty' seeks to win back fans with warfare spectacle
-
Ukraine says two soldiers died after arrested girl sent Russian poison
-
Volvo Cars shares plunge on losses, job cuts
-
New Greece law bans social media for under-15s
-
France braces for new protests as Macron seeks to restore order
-
Netanyahu orders West Bank closure as attack wounds Israelis before election
-
Kering shares tumble as Gucci fails to reassure investors
-
Asian stocks mixed ahead of weekend as tech recovers early losses
-
West Bank attack wounds 5 as Israel PM cancels events
-
How five Boeing 777s linked Madagascar's power elite to Iran
-
Ahead of APEC summit, Trump comes knocking on Kim's door
Ozempic slimming craze sweeps Kosovo despite side effects
Kosovo influencer Tringa Kadriu sees the slimming drug Ozempic as a chance to shed excess pounds -- and she is not the only one in her Balkan nation, where more than half the population is overweight.
"I want to lose 15-16 kilos (33-35 pounds) in two months," Kadriu, 29, told AFP, "and then I'll continue with fitness".
Ozempic, approved in the United States to treat diabetes in 2017, has found an international market for people trying to lose weight.
Despite its cost, the drug has soared in popularity in Kosovo, a country of 1.7 million.
While Kosovo authorities have not sanctioned the drug's use for weight loss, they have noted their limited means to confront use of a drug widely available in the country.
Merita Emini-Sadiku, who heads the Kosovo university hospital's endocrinology clinic, said the cost of the drug had soared.
"The monthly dose used to be 75-80 euros ($85-91), while now it is 130-140 euros ($147-159), probably due to high demand," she said.
But she warned that "Ozempic has side effects that people are not aware of".
Ozempic use can potentially cause issues including thyroid cancer, pancreatitis, gastroparesis and bowel obstruction, according to the latest studies.
- 'Constant demand' -
Meant to treat Type 2 diabetes -- of which the WHO says Kosovo has lower than average levels -- the drug regulates blood sugar levels but also helps suppress hunger, leading to a lower calorie intake.
As a result, its potentially cancerous complications have done little to stem the drug's popularity or availability.
"I checked a lot of pharmacies in Kosovo and I noticed that Ozempic is very easy to get," said Kadriu, adding that pharmacists even suggested she gradually increase her dosage.
A worker at a pharmacy in the capital Pristina's downtown, who asked to remain anonymous, said she had trouble recalling when someone last came into her pharmacy to buy Ozempic with a diabetes prescription.
"But we have a constant demand for Ozempic without a prescription. You can guess why," she said.
Given its availability, Emini-Sadiku said authorities should exercise greater control over Ozempic's distribution.
But Bujar Vitija, a journalist specialising in health, said that would be tricky to achieve given Kosovo's poor health record-keeping.
"Unfortunately there is no data," Vitija said.
With 1,500 to 1,600 private pharmacies in Kosovo, the country's 20 pharmaceutical inspectors have their work cut out for them, he added.
- Ozempic 'every day' -
While Kosovo has lower levels of obesity than the European average, more than 57 percent of the population is overweight and 20 percent is clinically obese, according to a 2019 World Health Organization report.
And women, who are more likely to face societal pressure to be thin, were 66 percent more likely to be obese than men, the WHO report found.
But not every Kosovar who has used Ozempic had the best experience with the drug.
"I took Ozempic on the advice of a doctor for two years but it had no effect," said 48-year-old merchant Lulzim Rrahmani, adding that three of his relatives even experienced "a negative effect of the drug".
"It was just a waste of money and time."
Given the risk of side effects, Emini-Sadiku said Ozempic was "by no means to be taken without a doctor's prescription".
Yet Kadriu said she would not be deterred, adding that she saw colleagues taking the drug "every day at work".
"I don't see any symptom that would deter me."
F.Dubois--AMWN